R&D Systems™ Recombinant Human LILRB3/CD85a/ILT5 Fc Chimera Protein

Catalog No.	Quantity
1806T5050	50 μg

Catalog No. 1806T5050 Supplier R&D Systems™ Supplier No. 1806T5050

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its ability to bind fluorescein-conjugated S. aureus Bioparticles. Jiang, Y. et al. (2006) J. Biol. Chem. 281:11834. The ED50 for this effect is 0.4-2 μg/mL.

Specifications

• Accession Number: AAB68668
• For Use With (Application): Binding Activity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 11025
• Molecular Weight (g/mol): M.W. (Observed): 95-105 kDa, reducing conditions; M.W. (theoretical): 72.6 kDa (monomer)
• Name: ILT5/CD85a Fc Chimera
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human LILRB3/CD85a/ILT5 protein Human ILRB3/CD85a/ILT5 (Gly24-Glu443) (N-terminus) Accession # AAB68668 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Structural Form: Disulfide linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: LILRB3
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 250 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: ILT5/CD85a/LILRB3